Tezepelumab normalizes serum interleukin-5 and -13 levels in patients with severe, uncontrolled asthma. Pham TH, Chen C, Colice G, Parnes JR, et al. Ann Allergy Asthma Immunol 2021 Aug 14. pii: S1081-1206(21)00566.

Read + Share

Amedeo Smart

Independent Medical Education

Pham TH, Chen C, Colice G, Parnes JR, et al. Tezepelumab normalizes serum interleukin-5 and -13 levels in patients with severe, uncontrolled asthma. Ann Allergy Asthma Immunol 2021 Aug 14. pii: S1081-1206(21)00566.
PMID: 34403803